| Application no. and date | 16202983.9 (espacenet) (Federated) (European Patent Register), 20120710 | | Patent/reg. no. and date | DK/EP 3255043, 20210120 | | Publication date | 20171213 | | Priority no. and date | US 201161506737 P, 20110712 | | EP pub. no. and date |
EP 3255043 20171213 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | 1589774 | | Inventor | CONNOLLY, Stephen, c/o AstraZeneca Intellectual Property,
AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4GT, GB,
EBDEN, Mark, Richard, C/o AstraZeneca Intellectual Property,
AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB,
LANGER, Thomas, AstraZeneca Charter Way
Macclesfield, Cheshire SK10 2NA, GB,
STEVEN, Alan, Robert, AstraZeneca Charter Way
Macclesfield, Cheshire SK10 2NA, GB,
STEWART, Craig, Robert, AstraZeneca, Charter Way
Macclesfield, Cheshire SK10 2NA, GB,
TOMLIN, Paula, Margaret, AstraZeneca Charter Way
Macclesfield, Cheshire SK10 2NA, GB,
WALTERS, Iain, Alastair, Stewart, C/o AstraZeneca Intellectual Property,
AstraZeneca R&D Alderley
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB,
WILLIAMS, Andrew, John, AstraZeneca,
Alderley Park
Macclesfield, Cheshire SK10 4TG, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 29/00 (2006.01) , A61P 37/00 (2006.01) , C07D 205/04 (2006.01) , C07D 403/12 (2006.01) | | Title | N-(6-((2R,3S)-3,4-DIHYDROXYBUTAN-2-YLOXY)-2-(4-FLUORBENZYLTHIO)PYRIMIDIN-4-YL)-3-METHYLAZETIDIN-1-SULFONAMID SOM KEMOKINRECEPTORMODULATOR | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
